Repurposing Drugs in Oncology: Next Steps

被引：56
|
作者：
Verbaanderd, Ciska [1 ,2 ]
Meheus, Lydie [1 ]
Huys, Isabelle [2 ]
Pantziarka, Pan [1 ,3 ]
机构：
[1] Anticanc Fund, B-1853 Brussels, Strombeek Bever, Belgium
[2] Univ Leuven, Dept Pharmaceut & Pharmacol Sci, Leuven, Belgium
[3] George Pantziarka TP53 Trust, London KT1 2JP, England
来源：
TRENDS IN CANCER | 2017年 / 3卷 / 08期
关键词：
ASPIRIN;
D O I：
10.1016/j.trecan.2017.06.007
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
The repurposing of existing non-cancer drugs is a potential source of new treatment options for cancer patients with high unmet medical needs. While scientific research is progressing rapidly in the field of drug repurposing, the implementation of drug repurposing still faces important financial and regulatory hurdles that should be addressed to optimise clinical adoption.
引用
收藏
页码：543 / 546
页数：4
相关论文
共 50 条
  • [21] Repurposing Drugs in Oncology (ReDO)-itraconazole as an anti-cancer agent
    Pantziarka, Pan
    Sukhatme, Vidula
    Bouche, Gauthier
    Meheus, Lydie
    Sukhatme, Vikas P.
    ECANCERMEDICALSCIENCE, 2015, 9
  • [22] Next-Generation Sequencing in Clinical Oncology: Next Steps Towards Clinical Validation
    Bennett, Nigel C.
    Farah, Camile S.
    CANCERS, 2014, 6 (04): : 2296 - 2312
  • [23] Next steps for IBM Watson Oncology: Scalability to additional malignancies.
    Epstein, Andrew S.
    Zauderer, Marjorie Glass
    Gucalp, Ayca
    Seidman, Andrew David
    Caroline, Aryeh
    Fu, Julia
    Keesing, Jeffrey
    Hsiao, Franny
    Megerian, Mark
    Eggebraaten, Thomas
    DeLima, Robert
    Setnes, Marie
    Bach, Peter
    Kris, Mark G.
    JOURNAL OF CLINICAL ONCOLOGY, 2014, 32 (15)
  • [24] From the Beginning of the Korean Gynecologic Oncology Group to the Present and Next Steps
    Min, Kyung-Jin
    Kim, Nam Kyeong
    Song, Jae-Yun
    Choi, Min Chul
    Lee, Shin Wha
    Lee, Keun Ho
    Kim, Min Kyu
    Kang, Sokbom
    Choi, Chel Hun
    Lee, Jeong-Won
    Lee, Eun-Ju
    Eom, Keun-Yong
    Kim, Sang Wun
    Cho, Hanbyoul
    Lee, Sun Joo
    Lim, Myong Cheol
    Bae, Jaeman
    Yoo, Chong Woo
    Kim, Kidong
    Kim, Dae-Yeon
    Lee, Chulmin
    Ryu, Sang Young
    Jeon, Seob
    Kim, Jae-Weon
    Nam, Byung-Ho
    Kang, Soon-Beom
    Kim, Kyung Tae
    Nam, Joo-Hyun
    Kim, Byoung-Gie
    Kim, Yong-Man
    Kim, Jae-Hoon
    CANCERS, 2024, 16 (19)
  • [25] In vitro, in silico and in vivo screening of non-oncology drugs for repurposing in osteosarcoma
    Desai, Sujit
    Manjappa, Arehalli
    Khulbe, Preeti
    Choudhar, Prafulla
    Kumbhar, Popat
    JOURNAL OF RESEARCH IN PHARMACY, 2023, 27 (02): : 712 - 721
  • [26] Drug Repurposing in Oncology
    Goenka, Luxitaa
    Ganesan, Prasanth
    INDIAN JOURNAL OF MEDICAL AND PAEDIATRIC ONCOLOGY, 2021, 42 (02) : 194 - 198
  • [27] Drug repurposing in oncology
    Bouche, Gauthier
    Gedye, Craig
    Meheus, Lydie
    Pantziarka, Pan
    LANCET ONCOLOGY, 2020, 21 (12): : E542 - E542
  • [28] Repurposing non-cancer drugs in oncology: Aspirin and metformin are only the tip of the iceberg
    Gyawali, B.
    Pantziarka, P.
    Meheus, L.
    Bouche, G.
    ANNALS OF ONCOLOGY, 2017, 28
  • [29] Geriatric Oncology: How Far Have We Gone and What Are the Next Steps?
    Kurtz, Jean-Emmanuel
    Heitz, Damien
    Kurtz-Illig, Valerie
    Dufour, Patrick
    ONCOLOGY, 2009, 77 (3-4) : 147 - 156
  • [30] The need for new drugs against tuberculosis - Obstacles, opportunities, and next steps
    O'Brien, RJ
    Nunn, PP
    AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE, 2001, 163 (05) : 1055 - 1058
12345